EGTX.ST STO
Egetis Therapeutics AB (publ)
1W: +16.5%
1M: +17.1%
3M: +55.6%
YTD: +77.6%
1Y: +74.5%
3Y: +121.7%
5Y: +70.6%
kr 9.18 ($0.91)
-0.26 (-2.75%)
Weekly Expected Move ±9.5%
kr 7
kr 8
kr 9
kr 10
kr 11
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$639M
-19.3% ▼
5Y CAGR: -6.5%
Total Liabilities
$300M
+0.3% ▲
5Y CAGR: +2.6%
Shareholders Equity
$339M
-31.3% ▼
5Y CAGR: -11.7%
Cash & Investments
$216M
-38.5% ▼
5Y CAGR: -5.6%
Total Debt
$76M
-34.8% ▼
5Y CAGR: +75.0%
Net Debt
-$139M
+40.4% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $144M | $128M | $303M | $351M | $216M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $144M | $128M | $303M | $351M | $216M |
| Net Receivables | $7M | $10M | $28M | $24M | $28M |
| Inventory | $694K | $600K | $700K | $1M | $2M |
| Other Current Assets | $0 | $7M | $9M | $0 | $100K |
| Total Current Assets | $153M | $147M | $346M | $380M | $254M |
| Property, Plant & Equip. | $4M | $3M | $4M | $3M | $10M |
| Goodwill & Intangibles | $411M | $410M | $409M | $408M | $373M |
| Long-Term Investments | $785K | $800K | $800K | $800K | $800K |
| Other Non-Current Assets | $785K | $700K | $0 | $200K | $0 |
| Total Non-Current Assets | $416M | $414M | $414M | $412M | $386M |
| Total Assets | $569M | $561M | $760M | $792M | $639M |
| — Liabilities — | |||||
| Accounts Payable | $5M | $20M | $29M | $26M | $22M |
| Short-Term Debt | $0 | $0 | $5M | $30M | $32M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $28M | $15M | $56M | $145M | $188M |
| Total Current Liabilities | $39M | $49M | $104M | $204M | $241M |
| Long-Term Debt | $0 | $0 | $103M | $84M | $45M |
| Other Non-Current Liab. | $360K | $4M | $5M | $10M | $13M |
| Total Non-Current Liabilities | $3M | $6M | $111M | $95M | $59M |
| Total Liabilities | $42M | $55M | $215M | $299M | $300M |
| — Equity — | |||||
| Common Stock | $9M | $11M | $15M | $20M | $22M |
| Retained Earnings | -$746M | -$940M | -$1.3B | -$1.6B | -$1.9B |
| Accumulated OCI | $1M | $6M | $17M | $25M | $0 |
| Total Stockholders Equity | $527M | $506M | $546M | $493M | $339M |
| Total Liabilities & Equity | $569M | $561M | $760M | $792M | $639M |
| — Key Metrics — | |||||
| Total Debt | $4M | $3M | $113M | $117M | $76M |
| Net Debt | -$140M | -$125M | -$190M | -$234M | -$139M |
| Total Investments | $785K | $800K | $800K | $800K | $800K |